TELCADIN-40 TAB

About

TELCADIN-40 TAB contains Telmisartan 40mg, an angiotensin II receptor blocker (ARB). This medication is primarily used for the treatment of essential hypertension and for cardiovascular risk reduction in patients aged 55 years or older who are at high risk of cardiovascular events. Telmisartan works by selectively blocking the binding of angiotensin II to the AT1 receptor in various tissues, including vascular smooth muscle and the adrenal gland. This action leads to vasodilation, reduced aldosterone secretion, and decreased sodium and water reabsorption, resulting in a significant reduction in blood pressure.

Its long duration of action allows for once-daily dosing, providing consistent blood pressure control throughout the 24-hour period. Telmisartan is also known for its renoprotective effects, particularly in patients with diabetic nephropathy. It is a well-tolerated medication, making it a suitable choice for long-term management of hypertension and for preventing serious cardiovascular complications such as stroke and myocardial infarction.

Uses

• Treatment of essential hypertension
• Cardiovascular risk reduction in high-risk patients
• Management of diabetic nephropathy (off-label)
• Heart failure (off-label)

Directions For Use

Take one tablet orally once daily, with or without food, as directed by your physician.

Benefits

• Effective and sustained blood pressure control
• Reduces the risk of cardiovascular events
• Convenient once-daily dosing regimen
• Provides renoprotective effects
• Well-tolerated with a favorable side effect profile
• Helps prevent stroke and myocardial infarction

Side Effects

• Dizziness
• Headache
• Fatigue
• Cough
• Back pain
• Diarrhea
• Nausea
• Abdominal pain
• Sinusitis
• Pharyngitis
• Muscle cramps
• Hyperkalemia (rare)

Safety Measures

• Alcohol - Alcohol may enhance the hypotensive effects of Telmisartan and increase the risk of dizziness or lightheadedness.
• Pregnancy - Contraindicated, especially during the second and third trimesters, due to potential fetal harm and toxicity.
• Breastfeeding - Not recommended; Telmisartan may pass into breast milk and could affect a nursing infant.
• Liver - Use with caution; dose adjustment may be necessary in patients with severe hepatic impairment.
• Kidney - Contraindicated in severe renal artery stenosis; monitor kidney function closely in all patients.
• Lung - Generally safe; no specific contraindications related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.